Isoforms of protein kinase C involved in phorbol ester-induced sphingosine 1-phosphate receptor 1 phosphorylation and desensitization

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 2, 2014, Pages 327-334

  Morquecho León, Marco Antonio ^a   Bazúa Valenti, Silvana ^a   Romero Ávila, M Teresa ^a   García Sáinz, J Adolfo ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

PKC; Protein kinase C; Receptor phosphorylation; S1P; S1P1; Sphingosine 1 phosphate; Sphingosine 1 phosphate receptor 1

Indexed keywords

PHORBOL ESTER; PROTEIN KINASE C; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; DESENSITIZATION; DOWN REGULATION; ELECTROPHORESIS; IMMUNOPRECIPITATION; PLASMID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSIENT EXPRESSION; WESTERN BLOTTING;

G PROTEIN-COUPLED RECEPTOR KINASE; GFP; GREEN FLUORESCENT PROTEIN; GRK; PKC; PROTEIN KINASE C; RECEPTOR PHOSPHORYLATION; S1P; S1P(1); SHORT HAIRPIN RNA; SHRNA; SPHINGOSINE-1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE RECEPTOR 1;

CALCIUM; CELL LINE, TUMOR; DOWN-REGULATION; GENES, DOMINANT; GREEN FLUORESCENT PROTEINS; HUMANS; INTRACELLULAR SPACE; ISOENZYMES; MUTANT PROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTORS, LYSOSPHINGOLIPID; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE;

EID: 84890132458     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.11.002     Document Type: Article

References (44)

1. Alvarez S.E., Milstien S., Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol. Metab. 2007, 18:300-307.
2. Jung B., Obinata H., Galvani S., Mendelson K., Ding B.S., Skoura A., Kinzel B., Brinkmann V., Rafii S., Evans T., Hla T. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. Dev. Cell 2012, 23:600-610.
3. Takuwa Y., Okamoto Y., Yoshioka K., Takuwa N. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. Biochim. Biophys. Acta 2008, 1781:483-488.
4. Ishii M., Kikuta J. Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim. Biophys. Acta 2013, 1831:223-227.
5. Donati C., Cencetti F., Bruni P. New insights into the role of sphingosine 1-phosphate and lysophosphatidic acid in the regulation of skeletal muscle cell biology. Biochim. Biophys. Acta 2013, 1831:176-184.
6. Rivera J., Proia R.L., Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 2008, 8:753-763.
7. Takuwa Y., Ikeda H., Okamoto Y., Takuwa N., Yoshioka K. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. Biochim. Biophys. Acta 2013, 1831:185-192.
8. Pyne N.J., Pyne S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 2010, 10:489-503.
9. Chun J., Goetzl E.J., Hla T., Igarashi Y., Lynch K.R., Moolenaar W., Pyne S., Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 2002, 54:265-269.
10. Sanchez T., Hla T. Structural and functional characteristics of S1P receptors. J. Cell. Biochem. 2004, 92:913-922.
11. Hla T., Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 1990, 265:9308-9313.
12. Lee M.J., Thangada S., Liu C.H., Thompson B.D., Hla T. Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist. J. Biol. Chem. 1998, 273:22105-22112.
13. Hanson M.A., Roth C.B., Jo E., Griffith M.T., Scott F.L., Reinhart G., Desale H., Clemons B., Cahalan S.M., Schuerer S.C., Sanna M.G., Han G.W., Kuhn P., Rosen H., Stevens R.C. Crystal structure of a lipid G protein-coupled receptor. Science 2012, 335:851-855.
14. Fieger C.B., Huang M.C., Van Brocklyn J.R., Goetzl E.J. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines. FASEB J. 2005, 19:1926-1928.
15. Ohno Y., Ito A., Ogata R., Hiraga Y., Igarashi Y., Kihara A. Palmitoylation of the sphingosine 1-phosphate receptor S1P is involved in its signaling functions and internalization. Genes Cells 2009, 14:911-923.
16. Oo M.L., Thangada S., Wu M.T., Liu C.H., Macdonald T.L., Lynch K.R., Lin C.Y., Hla T. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J. Biol. Chem. 2007, 282:9082-9089.
17. Oo M.L., Chang S.H., Thangada S., Wu M.T., Rezaul K., Blaho V., Hwang S.I., Han D.K., Hla T. Engagement of S1P-degradative mechanisms leads to vascular leak in mice. J. Clin. Invest. 2011, 121:2290-2300.
18. Watterson K.R., Johnston E., Chalmers C., Pronin A., Cook S.J., Benovic J.L., Palmer T.M. Dual regulation of EDG1/S1P(1) receptor phosphorylation and internalization by protein kinase C and G-protein-coupled receptor kinase 2. J. Biol. Chem. 2002, 277:5767-5777.
19. Lee M.J., Thangada S., Paik J.H., Sapkota G.P., Ancellin N., Chae S.S., Wu M., Morales-Ruiz M., Sessa W.C., Alessi D.R., Hla T. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell 2001, 8:693-704.
20. Qanbar R., Bouvier M. Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol. Ther. 2003, 97:1-33.
21. García-Sáinz J.A., Vázquez-Prado J., Medina L.C. Alpha 1-adrenoceptors: function and phosphorylation. Eur. J. Pharmacol. 2000, 389:1-12.
22. Tobin A.B. G-protein-coupled receptor phosphorylation: where, when and by whom. Br. J. Pharmacol. 2008, 153(Suppl. 1):S167-S176.
23. Vázquez-Prado J., Casas-González P., García-Sáinz J.A. G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein-protein interactions. Cell. Signal. 2003, 15:549-557.
24. Ferguson S.S. Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol. Sci. 2007, 28:173-179.
25. Arnon T.I., Xu Y., Lo C., Pham T., An J., Coughlin S., Dorn G.W., Cyster J.G. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 2011, 333:1898-1903.
26. Thompson B., Ancellin N., Fernandez S.M., Hla T., Sha'afi R.I. Protein kinase Calpha and sphingosine 1-phosphate-dependent signaling in endothelial cell. Prostaglandins Other Lipid Mediat. 2006, 80:15-27.
27. Wu-Zhang A.X., Newton A.C. Protein kinase C pharmacology: refining the toolbox. Biochem. J. 2013, 452:195-209.
28. Sensken S.C., Graler M.H. Down-regulation of S1P1 receptor surface expression by protein kinase C inhibition. J. Biol. Chem. 2010, 285:6298-6307.
29. Graeler M.H., Kong Y., Karliner J.S., Goetzl E.J. Protein kinase C epsilon dependence of the recovery from down-regulation of S1P1 G protein-coupled receptors of T lymphocytes. J. Biol. Chem. 2003, 278:27737-27741.
30. Bergelin N., Lof C., Balthasar S., Kalhori V., Tornquist K. S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration. Endocrinology 2010, 151:2994-3005.
31. Liu C.H., Thangada S., Lee M.J., Van Brocklyn J.R., Spiegel S., Hla T. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol. Biol. Cell 1999, 10:1179-1190.
32. Soh J.W., Weinstein I.B. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J. Biol. Chem. 2003, 278:34709-34716.
33. Avendaño-Vázquez S.E., García-Caballero A., García-Sáinz J.A. Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1. Biochem. J. 2005, 385:677-684.
34. Castillo-Badillo J.A., Molina-Munoz T., Romero-Avila M.T., Vazquez-Macias A., Rivera R., Chun J., Garcia-Sainz J.A. Sphingosine 1-phosphate-mediated alpha1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions. Biochim. Biophys. Acta 2012, 1823:245-254.
35. Gibbs T.C., Rubio M.V., Zhang Z., Xie Y., Kipp K.R., Meier K.E. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells. Prostate 2009, 69:1493-1506.
36. Akao Y., Banno Y., Nakagawa Y., Hasegawa N., Kim T.J., Murate T., Igarashi Y., Nozawa Y. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem. Biophys. Res. Commun. 2006, 342:1284-1290.
37. Lee H., Deng J., Kujawski M., Yang C., Liu Y., Herrmann A., Kortylewski M., Horne D., Somlo G., Forman S., Jove R., Yu H. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat. Med. 2010, 16:1421-1428.
38. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
39. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 1993, 268:9194-9197.
40. Anastassiadis T., Deacon S.W., Devarajan K., Ma H., Peterson J.R. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol. 2011, 29:1039-1045.
41. Gonindard C., Bergonzi C., Denier C., Sergheraert C., Klaebe A., Chavant L., Hollande E. Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro. Cell Biol. Toxicol. 1997, 13:141-153.
42. Gschwendt M., Muller H.J., Kielbassa K., Zang R., Kittstein W., Rincke G., Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 1994, 199:93-98.
43. Jirousek M.R., Gillig J.R., Gonzalez C.M., Heath W.F., McDonald J.H., Neel D.A., Rito C.J., Singh U., Stramm L.E., Melikian-Badalian A., Baevsky M., Ballas L.M., Hall S.E., Winneroski L.L., Faul M.M. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. J. Med. Chem. 1996, 39:2664-2671.
44. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 1997, 272:952-960.